Cargando…
Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach
The novel coronavirus 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a wide range of manifestations. In this regard, growing evidence is focusing on COVID-19 neurological associations; however, there is a lack of established pathophysiological mechani...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941749/ https://www.ncbi.nlm.nih.gov/pubmed/33708124 http://dx.doi.org/10.3389/fphar.2020.621099 |
_version_ | 1783662189323747328 |
---|---|
author | Fakhri, Sajad Piri, Sana Majnooni, Mohammad Bagher Farzaei, Mohammad Hosein Echeverría, Javier |
author_facet | Fakhri, Sajad Piri, Sana Majnooni, Mohammad Bagher Farzaei, Mohammad Hosein Echeverría, Javier |
author_sort | Fakhri, Sajad |
collection | PubMed |
description | The novel coronavirus 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a wide range of manifestations. In this regard, growing evidence is focusing on COVID-19 neurological associations; however, there is a lack of established pathophysiological mechanisms and related treatments. Accordingly, a comprehensive review was conducted, using electronic databases, including PubMed, Scopus, Web of Science, and Cochrane, along with the author’s expertize in COVID-19 associated neuronal signaling pathways. Besides, potential phytochemicals have been provided against neurological signs of COVID-19. Considering a high homology among SARS-CoV, Middle East Respiratory Syndrome and SARS-CoV-2, revealing their precise pathophysiological mechanisms seems to pave the road for the treatment of COVID-19 neural manifestations. There is a complex pathophysiological mechanism behind central manifestations of COVID-19, including pain, hypo/anosmia, delirium, impaired consciousness, pyramidal signs, and ischemic stroke. Among those dysregulated neuronal mechanisms, neuroinflammation, angiotensin-converting enzyme 2 (ACE2)/spike proteins, RNA-dependent RNA polymerase and protease are of special attention. So, employing multi-target therapeutic agents with considerable safety and efficacy seems to show a bright future in fighting COVID-19 neurological manifestations. Nowadays, natural secondary metabolites are highlighted as potential multi-target phytochemicals in combating several complications of COVID-19. In this review, central pathophysiological mechanisms and therapeutic targets of SARS-CoV-2 has been provided. Besides, in terms of pharmacological mechanisms, phytochemicals have been introduced as potential multi-target agents in combating COVID-19 central nervous system complications. |
format | Online Article Text |
id | pubmed-7941749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79417492021-03-10 Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach Fakhri, Sajad Piri, Sana Majnooni, Mohammad Bagher Farzaei, Mohammad Hosein Echeverría, Javier Front Pharmacol Pharmacology The novel coronavirus 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a wide range of manifestations. In this regard, growing evidence is focusing on COVID-19 neurological associations; however, there is a lack of established pathophysiological mechanisms and related treatments. Accordingly, a comprehensive review was conducted, using electronic databases, including PubMed, Scopus, Web of Science, and Cochrane, along with the author’s expertize in COVID-19 associated neuronal signaling pathways. Besides, potential phytochemicals have been provided against neurological signs of COVID-19. Considering a high homology among SARS-CoV, Middle East Respiratory Syndrome and SARS-CoV-2, revealing their precise pathophysiological mechanisms seems to pave the road for the treatment of COVID-19 neural manifestations. There is a complex pathophysiological mechanism behind central manifestations of COVID-19, including pain, hypo/anosmia, delirium, impaired consciousness, pyramidal signs, and ischemic stroke. Among those dysregulated neuronal mechanisms, neuroinflammation, angiotensin-converting enzyme 2 (ACE2)/spike proteins, RNA-dependent RNA polymerase and protease are of special attention. So, employing multi-target therapeutic agents with considerable safety and efficacy seems to show a bright future in fighting COVID-19 neurological manifestations. Nowadays, natural secondary metabolites are highlighted as potential multi-target phytochemicals in combating several complications of COVID-19. In this review, central pathophysiological mechanisms and therapeutic targets of SARS-CoV-2 has been provided. Besides, in terms of pharmacological mechanisms, phytochemicals have been introduced as potential multi-target agents in combating COVID-19 central nervous system complications. Frontiers Media S.A. 2021-01-20 /pmc/articles/PMC7941749/ /pubmed/33708124 http://dx.doi.org/10.3389/fphar.2020.621099 Text en Copyright © 2021 Fakhri, Piri, Majnooni, Farzaei and Echeverría. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Fakhri, Sajad Piri, Sana Majnooni, Mohammad Bagher Farzaei, Mohammad Hosein Echeverría, Javier Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach |
title | Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach |
title_full | Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach |
title_fullStr | Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach |
title_full_unstemmed | Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach |
title_short | Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach |
title_sort | targeting neurological manifestations of coronaviruses by candidate phytochemicals: a mechanistic approach |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941749/ https://www.ncbi.nlm.nih.gov/pubmed/33708124 http://dx.doi.org/10.3389/fphar.2020.621099 |
work_keys_str_mv | AT fakhrisajad targetingneurologicalmanifestationsofcoronavirusesbycandidatephytochemicalsamechanisticapproach AT pirisana targetingneurologicalmanifestationsofcoronavirusesbycandidatephytochemicalsamechanisticapproach AT majnoonimohammadbagher targetingneurologicalmanifestationsofcoronavirusesbycandidatephytochemicalsamechanisticapproach AT farzaeimohammadhosein targetingneurologicalmanifestationsofcoronavirusesbycandidatephytochemicalsamechanisticapproach AT echeverriajavier targetingneurologicalmanifestationsofcoronavirusesbycandidatephytochemicalsamechanisticapproach |